BridgeBio Pharma, Inc. (BBIO)
NASDAQ·Healthcare·Biotechnology
$73.51
-0.97%
Mkt Cap $14.47B
Analyst Ratings
Buy
21
Hold
2
Sell
0
Price Target (52 analysts)
$110.09
Range $97.00 – $130.00
Implied Upside
+49.8%
Consensus $110.09 vs current $73.51
NASDAQ·Healthcare·Biotechnology
$73.51
-0.97%
Mkt Cap $14.47B
Buy
21
Hold
2
Sell
0
Price Target (52 analysts)
$110.09
Range $97.00 – $130.00
+49.8%
Consensus $110.09 vs current $73.51